drugset / Trial / NCT06979973
A Drug-drug Interaction Study to Investigate the Pharmacokinetic Interactions Between CKD-508, Midazolam, and Rosuvastatin in Healthy Adult Male Participants
NaSingle-groupOpen-labelTreatment
Summary
Phase 1, open-label, non-randomized, three-treatment, one-sequence interaction study to evaluate the PK interactions between CKD-508, midazolam, and rosuvastatin in healthy adult male participants
Timeline
- Start
- 2025-05-14
- Primary completion
- 2025-08-17
- Completion
- 2025-08-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CKD-508 | Unknown | — | — |
| Subject | Midazolam | Small molecule | — | — |
| Subject | Rosuvastatin | Small molecule | — | — |
Indications
No indication recorded.